This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Vanderbilt University. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: The Innovations of Seth Zost
Introduction
Seth Zost is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. With a total of 2 patents, Zost's work is crucial in addressing global health challenges.
Latest Patents
Zost's latest patents focus on human monoclonal antibodies targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present disclosures are directed to antibodies that bind to and neutralize the coronavirus designated SARS-CoV-2, along with methods for their use. These innovations are vital in the ongoing fight against COVID-19.
Career Highlights
Seth Zost is affiliated with Vanderbilt University, where he conducts his research and development. His work at this esteemed institution allows him to collaborate with leading experts in the field, enhancing the impact of his inventions.
Collaborations
Some of Zost's notable coworkers include Robert Carnahan and James E Crowe, Jr. Their combined expertise contributes to the advancement of research in monoclonal antibodies and infectious diseases.
Conclusion
Seth Zost's contributions to the field of biotechnology, particularly through his patents on antibodies for SARS-CoV-2, highlight his role as an innovative inventor. His work at Vanderbilt University and collaborations with esteemed colleagues further underscore the importance of his research in addressing critical health issues.